ASHLEY KEMP: Open Payments
NPI 1790431807 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,259 in 91 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,259
Food & beverage: $2,091Education: $168
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $777 |
| Janssen Biotech, Inc. | 15 | $623 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $220 |
| Ardelyx, Inc. | 7 | $177 |
| GENZYME CORPORATION | 4 | $108 |
| Madrigal Pharmaceuticals | 3 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| Janssen Scientific Affairs, LLC | 1 | $43 |
| PFIZER INC. | 2 | $40 |
| Lilly USA, LLC | 1 | $23 |
Products named: TREMFYA, RINVOQ, ENTYVIO, IBSRELA, DUPIXENT, SKYRIZI, REZDIFFRA, CREON.
Industry payments across TX — which companies pay providers there.
